Anti-FIXa x Anti-FX Bispecific Antibody (IgG-IgG) (BSIG-162)

Anti-FIXa x Anti-FX Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-FIXa and anti-FX parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can bind and dimerize two factors. It acts as mimetic FXIII. It is designed for the research of Hemophilia A therapy.

Datasheet INQUIRY

Specifications

Targets

FIXa & FX

Type

IgG-IgG

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Hemophilia A

Targets

Target 1

FIXa

Gene ID

2158

UniProt ID

P00740

Alternative Names

F9; coagulation factor IX; FIX; P19; PTC; HEMB; THPH8; F9 p22; FIX F9; factor 9; factor IX F9; Christmas factor; plasma thromboplastic component; plasma thromboplastin component

Target 2

Gene ID

2159

UniProt ID

P00742

Alternative Names

F10; coagulation factor X; FX; FXA; factor Xa; prothrombinase; Stuart-Prower factor

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-FIXa x Anti-FX Bispecific Antibody (IgG-IgG) (BSIG-162). Click the button below to contact us or submit your feedback about this product.

Anti-FIXa x Anti-FX Bispecific Antibody (IgG-IgG) (CAT#: BSIG-162)

Specifications

Targets

Customer Reviews and Q&As